These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2454120)

  • 1. Immunologic dysfunction in scleroderma: evidence for increased mast cell releasability and HLA-DR positivity in the dermis.
    Pearson ME; Huff JC; Giorno RC; Panicheewa S; Claman HN; Steigerwald JC
    Arthritis Rheum; 1988 May; 31(5):672-7. PubMed ID: 2454120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dermal mast cell degranulation in systemic sclerosis.
    Seibold JR; Giorno RC; Claman HN
    Arthritis Rheum; 1990 Nov; 33(11):1702-9. PubMed ID: 2242067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased dermal mast cell populations in progressive systemic sclerosis: a link in chronic fibrosis?
    Hawkins RA; Claman HN; Clark RA; Steigerwald JC
    Ann Intern Med; 1985 Feb; 102(2):182-6. PubMed ID: 3966756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Scleroderma: DR antigens, autoantibodies and clinical manifestations.
    Alarcón GS; McCarty GA; Lanyon P; Phillips RM; Acton RT; Barger BO
    Clin Exp Rheumatol; 1987; 5(4):317-21. PubMed ID: 3326691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of epidermal Langerhans' cells and endothelial cell HLA-DR antigens in the skin in progressive systemic sclerosis.
    Andrews BS; Friou GJ; Barr RJ; Mirick GR; Berman M; Sandborg C; Ross PA
    J Rheumatol; 1986 Apr; 13(2):341-8. PubMed ID: 2941574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dermal mast cells in scleroderma: their skin density, tryptase/chymase phenotypes and degranulation.
    Akimoto S; Ishikawa O; Igarashi Y; Kurosawa M; Miyachi Y
    Br J Dermatol; 1998 Mar; 138(3):399-406. PubMed ID: 9580789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absence of MHC class II antigen on mast cells at sites of inflammation in human skin.
    Lipski S; Grabbe J; Henz BM
    Exp Dermatol; 1996 Apr; 5(2):120-4. PubMed ID: 8734922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA-DR antigens in epithelioid cell granulomas of sarcoidosis, using semithin frozen sections. A concept about granuloma formation.
    v Maarsseveen T; Mullink R; Rensen R; Stam J
    Sarcoidosis; 1985 Sep; 2(2):148-53. PubMed ID: 2436274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant expression of HLA-DR antigen on valvular fibroblasts from patients with active rheumatic carditis.
    Amoils B; Morrison RC; Wadee AA; Marcus R; Ninin D; King P; Sareli P; Levin S; Rabson AR
    Clin Exp Immunol; 1986 Oct; 66(1):88-94. PubMed ID: 3542318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA-DR antigen expression on keratinocytes in highly inflamed parts of psoriatic lesions.
    Terui T; Aiba S; Kato T; Tanaka T; Tagami H
    Br J Dermatol; 1987 Jan; 116(1):87-93. PubMed ID: 2434124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mast cell changes in scleroderma. Presence of MCT cells in the skin and evidence of mast cell activation.
    Irani AM; Gruber BL; Kaufman LD; Kahaleh MB; Schwartz LB
    Arthritis Rheum; 1992 Aug; 35(8):933-9. PubMed ID: 1642658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of HLA-DR molecules by keratinocytes, and presence of Langerhans cells in the dermal infiltrate of active psoriatic plaques.
    Gottlieb AB; Lifshitz B; Fu SM; Staiano-Coico L; Wang CY; Carter DM
    J Exp Med; 1986 Oct; 164(4):1013-28. PubMed ID: 2428913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Langerhans cells in prurigo nodularis investigated by HLA-DR and S-100 immunofluorescence double staining.
    Johansson O; Liang Y; Heilborn JD; Marcusson JA
    J Dermatol Sci; 1998 May; 17(1):24-32. PubMed ID: 9651825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mast cell numbers in diffuse scleroderma.
    Nishioka K; Kobayashi Y; Katayama I; Takijiri C
    Arch Dermatol; 1987 Feb; 123(2):205-8. PubMed ID: 3813593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of HLA-DR antigen in skin from patients with psoriasis.
    Morhenn VB; Abel EA; Mahrle G
    J Invest Dermatol; 1982 Feb; 78(2):165-8. PubMed ID: 6173446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ubiquitous expression of HLA-DR antigens on human small intestinal epithelium.
    Chiba M; Iizuka M; Masamune O
    Gastroenterol Jpn; 1988 Apr; 23(2):109-16. PubMed ID: 3290039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T lymphocytes in lesional skin of patients with dermatitis herpetiformis.
    Garioch JJ; Baker BS; Leonard JN; Fry L
    Br J Dermatol; 1994 Dec; 131(6):822-6. PubMed ID: 7857834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA-DR expression, natural killer cells and IgE containing cells in the jejunal mucosa of coeliac children.
    Arato A; Savilahti E; Tainio VM; Verkasalo M; Klemola T
    Gut; 1987 Aug; 28(8):988-94. PubMed ID: 3311907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of class II-MHC antigens in the dermis of patients with progressive systemic sclerosis.
    Gruschwitz M; Sepp N; Kofler H; Wick G
    Immunobiology; 1991 Jun; 182(3-4):234-55. PubMed ID: 1833311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of HLA class II antigens on skin fibroblasts in scleroderma.
    Branchet MC; Boisnic S; Blétry O; Robert L; Charron D; Francès C
    Br J Dermatol; 1992 May; 126(5):431-5. PubMed ID: 1610682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.